Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trichlorethanol SCHEMBL325071 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL7261325 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL291748 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL759616 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL1436780 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL8522341 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL16162174 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL4450822 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL762332 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR | |
| Trichlorethanol SCHEMBL6898269 | 1.00 | LMNA (0.33) | LMNATDP1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1067 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103059027-A | Method for preparing tebipenem pivoxil | ANHUI YOUCARE KAIYUE PHARMACEUTICAL CO LTD | 2013-04-24 | — | — | CN | claimed |
| CN-113321942-B | Sensitizing dye, sensitizing dye composition for photoelectric conversion, photoelectric conversion element, and dye sensitized solar cell | 保土谷化学工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-109415468-B | Electro-optical polymers | 国立研究开发法人情报通信研究机构 | 2024-06-07 | — | — | CN | disclosed |
| CN-118063531-A | Preparation and application of macrolide compound PA-46101s C-E | 中国科学院南海海洋研究所 | 2024-05-24 | — | — | CN | disclosed |
| EP-4368628-A1 | METHOD FOR PURIFYING NUCLEOTIDES, DEVICE FOR PURIFYING NUCLEOTIDES, HYDROPHOBIC REAGENT, AND HYDROPHOBIC SUBSTRATE | Japan Science and Technology Agency (JP) | 2024-05-15 | — | — | EP | disclosed |
| US-20240150367-A1 | NITROGEN-CONTAINING SPIRO CYCLIC COMPOUNDS AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2024-05-09 | — | — | US | disclosed |
| WO-2024080361-A1 | IMIDAZOLE DERIVATIVE | 株式会社 三和化学研究所 | 2024-04-18 | — | — | WO | disclosed |
| CN-117858885-A | Method and device for purifying nucleotide, and hydrophobic reagent and hydrophobic substrate | 国立研究开发法人科学技术振兴机构 | 2024-04-09 | — | — | CN | disclosed |
| US-20240092784-A1 | CONDENSED HETEROCYCLIC COMPOUND | NISSAN CHEMICAL CORPORATION (JP) | 2024-03-21 | — | — | US | disclosed |
| WO-2024014536-A1 | REAGENT FOR DETECTING SARS-RELATED CORONAVIRUS | 国立研究開発法人産業技術総合研究所 | 2024-01-18 | — | — | WO | disclosed |
| EP-0187022-A2 | Phospholipid conjugates and their preparation | TECHNICON INSTRUMENTS CORPORATION(a Delaware corporation) (US) | 1986-07-09 | — | — | EP | disclosed |
| US-4599333-A | HYPOTENSIVE AGENTS | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1986-07-08 | — | — | US | disclosed |
| EP-0181110-A2 | Histidine derivatives as renin inhibitors | Kissei Pharmaceutical Co. Ltd. (JP) | 1986-05-14 | — | — | EP | disclosed |
| EP-0157609-A2 | Lipid derivatives their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-10-09 | — | — | EP | disclosed |
| US-4463171-A | BACTERICIDES | SANRAKU-OCEAN CO., LTD. (JP) | 1984-07-31 | — | — | US | disclosed |
| EP-0110396-A2 | Iron-tetraphenylporphine complex having phosphocholine group and oxygen adsorbing and desorbing agent | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1984-06-13 | — | — | EP | disclosed |
| EP-0097202-A1 | Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1984-01-04 | — | — | EP | disclosed |
| EP-0071251-A1 | Novel aminoglycosides and use thereof | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1983-02-09 | — | — | EP | disclosed |
| EP-0018155-A2 | Novel cephalosporin compounds, a process for the preparation thereof, pharmaceutical compositions containing the same and the use thereof as a therapeutic agent against a microorganism | NOVO NORDISK A/S (DK) | 1980-10-29 | — | — | EP | disclosed |
| US-3993683-A | ANTITHROMBOTIC, ANTICHOLESTEREMICS, ANTICOAGULANTS | BOEHRINGER INGELHEIM GMBH (DT) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150367-A1 | NITROGEN-CONTAINING SPIRO CYCLIC COMPOUNDS AND PHARMACEUTICAL USE THEREOF | REN, PKD1, NPR1 | LMNA 4098/4885TDP1 4671/4885TP53 1064/4885 |
| US-20240092784-A1 | CONDENSED HETEROCYCLIC COMPOUND | SPR, QDPR, SUCNR1 | LMNA 2911/4885TDP1 1193/4885TP53 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.